Time-updated patterns of hemoglobin and hematocrit and the risk of CKD progression
Maintenance of stable and higher Hb levels of 110-130 g/L and HCT levels of 35%-40% in patients with CKD stages 3-4 is both protective and reliable in delaying CKD progression.
Authors
- Xiaoxuan Hu (ORCID: https://orcid.org/0000-0002-2579-1385)
- Lizhe Fu
- Huifen Chen (ORCID: https://orcid.org/0000-0001-8273-9295)
- Yi Shen (ORCID: https://orcid.org/0000-0002-2144-882X)
- Yifan Wu (ORCID: https://orcid.org/0000-0002-8498-8436)
- Xusheng Liu (ORCID: https://orcid.org/0000-0002-0931-4925)
- Xianlong Zhang (ORCID: https://orcid.org/0000-0003-0718-8993)
- Fang Tang (ORCID: https://orcid.org/0000-0002-4378-594X)
- Zhenjie Liu (ORCID: https://orcid.org/0000-0002-7757-5916)
- Wenwei Ouyang (ORCID: https://orcid.org/0000-0002-5070-6365)
Institutions
- Guangzhou University of Chinese Medicine (CN)
- Key Laboratory of Guangdong Province (CN)
- Global Policy Institute (US)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-10-30
- DOI
- https://doi.org/10.3389/fendo.2025.1642307
- Primary Topic
- Erythropoietin and Anemia Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- National Natural Science Foundation of China
- National Key Research and Development Program of China